HIMS241108C11000
- 8.30
- 0.000.00%
Hims & Hers Health Newsroom
Hims & Hers Health Options Spot-On: On November 5th, 162.7K Contracts Were Traded, With 342.86K Open Interest
Hims & Hers Stock Rises on Earnings and Planned Generic Version of Novo Nordisk Diabetes Drug -- Barrons.com
What's Going On With Hims & Hers Health Stock Tuesday?
Hims & Hers Core Business Looked Strong in 3Q -- Market Talk
Hims & Hers Still Benefiting From Unmet GLP-1 Demand -- Market Talk
Express News | Top 10 Trending Stocks On WallStreetBets As Of November 5, 2024 (Via Swaggy Stocks)
Seaport Global Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $32
Sector Update: Health Care
TD Cowen Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $25
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Hims & Hers Health Is Maintained at Buy by Canaccord Genuity
Hims & Hers Health Price Target Raised to $28.00/Share From $24.00 by Canaccord Genuity
Hims & Hers Health Analyst Ratings
A Quick Look at Today's Ratings for Hims & Hers Health(HIMS.US), With a Forecast Between $21 to $28
Social Buzz: Wallstreetbets Stocks Advance Premarket Tuesday; Palantir Technologies, Hims & Hers Health to Open Higher
Hims & Hers to Launch a Generic for Novo's Older GLP-1
Ryan MacDonald's Buy Rating on Hims & Hers Health Driven by Strong Performance and Strategic Initiatives
Express News | Hims & Hers Health Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Revenue Guidance Above Estimates
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Piper Sandler Remains a Hold on Hims & Hers Health (HIMS)